Short term view - SARTORIUS STEDIM BIOTECH : The ascending support has been breached.
In our previous short term analysis (14/11/2016), we were negative.We remain negative with a target at 52,6 € and an invalidation level at 62,5 €.
The trend has reversed to the downside.
Arguments :
- The ascending support has been breached.
- The falling moving average...
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.